Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038)

NCT01422304 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1198

Enrollment

INDUSTRY

Sponsor class

Conditions

Neuromuscular Blockade
Arthroplasty, Replacement, Hip
Arthroplasty, Replacement, Knee
Blood Coagulation
Antithrombotic Agents

Interventions

DRUG: Sugammadex
DRUG: neostigmine and glycopyrrolate or atropine
DRUG: Placebo to neostigmine
DRUG: Placebo to sugammadex

Sponsor

Merck Sharp & Dohme LLC